| Insurance Carrier | Facility/Professional | Modifier | Low Price | Median Price | High Price |
|---|---|---|---|---|---|
Aetna
| Facility | $557,317.93 | $557,317.93 | $557,317.93 | |
Aetna
| Professional | $557,317.93 | $557,317.93 | $585,183.82 | |
BCBS
| Facility | $60,175.49 | $73,025.77 | $98,243.04 |
Idecabtagene vicleucel, up to 510 million autologous B-cell maturation antigen (BCMA) directed CAR-positive T cells, including leukapheresis and dose preparation procedures, per therapeutic dose
| Insurance Carrier | Facility/Professional | Modifier | Low Price | Median Price | High Price |
|---|---|---|---|---|---|
Aetna
| Facility | $557,317.93 | $557,317.93 | $557,317.93 | |
Aetna
| Professional | $557,317.93 | $557,317.93 | $585,183.82 | |
BCBS
| Facility | $60,175.49 | $73,025.77 | $98,243.04 |